---
category: news
title: "BioXcel Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Formulation for BXCL501 and Methods of Treating Agitation"
excerpt: "BioXcel Therapeutics, Inc. (\"BTI\" or \"Company\") (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology,"
publishedDateTime: 2020-08-01T10:59:00Z
webUrl: "https://www.marketwatch.com/press-release/bioxcel-therapeutics-announces-notice-of-allowance-for-us-patent-application-covering-formulation-for-bxcl501-and-methods-of-treating-agitation-2020-07-07"
type: article
quality: 17
heat: -1
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
    width: 1200
    height: 630
    isCached: true

related:
  - title: "Seragon Announces GenomeScore™, the First AI Platform to Measure Rate of Aging and Physiological Changes"
    excerpt: "Aug. 4, 2020 /PRNewswire/ -- Seragon Pharmaceuticals, Inc. today announced GenomeScore™, the first artificial intelligence platform combining ... advancements to the fields of metabolism, gene therapy and bioinformatics. From the research end to ..."
    publishedDateTime: 2020-08-04T14:40:00Z
    webUrl: "https://www.prnewswire.com/news-releases/seragon-announces-genomescore-the-first-ai-platform-to-measure-rate-of-aging-and-physiological-changes-301105774.html"
    type: article
    provider:
      name: PR Newswire
      domain: prnewswire.com
    quality: 22
    images:
      - url: "https://mma.prnewswire.com/media/1218270/Seragon_Pharmaceuticals_Logo.jpg?p=facebook"
        width: 1200
        height: 628
        isCached: true

secured: "ywAPsTFJ0p+7oEzgYTKRco4scOlbXG8G9rcTJscbSv+a4n3iflnacuZiEGrQWXGwGEm6c9tWfdzlXoTaX/+3M3X0s1OBvpmrFPHBNjYeqG+JGwKR6qID+z/WA386HrianS6RRwWljtbvQ3BfcHSc8/OHwMFSXsoKh1agcOh8w+wTo3y0vRQTbNxQJ5Fli5ZAhh+NEco0HfmjbpKaMgcnjAzIf77pS96RlTDFditAkg/MTuss9fY0WFgDMwf8mi1SUsJ4Y94zZyDyaorWjRI26mxPbgSu27z7qZPy404og1Mq6D9BLtvl2hsnUbJIqmUuEu06WZQwlrEu12GIEj3fmg==;Vd5xlQMX9bGG/Nra9rDKfg=="
---

